Fernando Cabanillas

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Esmaeli B; McLaughlin P; Pro B; Samaniego F; Gayed I; Hagemeister F; Romaguera J; Cabanillas F; Neelapu S S; Banay R; Fayad L; Wayne Saville M; Kwak L W
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Wang Michael; Fayad Luis; Cabanillas Fernando; Hagemeister Fredrick; McLaughlin Peter; Rodriguez Maria A; Kwak Larry W; Zhou Yuhong; Kantarjian Hagop; Romaguera Jorge
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Overman M J; Feng L; Pro B; McLaughlin P; Hess M; Samaniego F; Younes A; Romaguera J E; Hagemeister F B; Kwak L; Cabanillas F; Rodriguez M A; Fayad L E
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Fernando Cabanillas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Esmaeli B; McLaughlin P; Pro B; Samaniego F; Gayed I; Hagemeister F; Romaguera J; Cabanillas F; Neelapu S S; Banay R; Fayad L; Wayne Saville M; Kwak L W
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):709-14.
2008: Wang Michael; Fayad Luis; Cabanillas Fernando; Hagemeister Fredrick; McLaughlin Peter; Rodriguez Maria A; Kwak Larry W; Zhou Yuhong; Kantarjian Hagop; Romaguera Jorge
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Cancer 2008;113(10):2734-41.
2008: Overman M J; Feng L; Pro B; McLaughlin P; Hess M; Samaniego F; Younes A; Romaguera J E; Hagemeister F B; Kwak L; Cabanillas F; Rodriguez M A; Fayad L E
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):553-9.
2006: Visco Carlo; Nadali Gianpaolo; Vassilakopoulos Theodoros P; Bonfante Valeria; Viviani Simonetta; Gianni Alessandro M; Federico Massimo; Luminari Stefano; Peethambaram Prema; Witzig Thomas E; Pangalis Gerassimos; Cabanillas Fernando; Medeiros L Jeffrey; Sarris Andreas H; Pizzolo Giovanni
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
European journal of haematology 2006;77(5):387-94.
2006: Pro Barbara; Hagemeister Fredrick B; McLaughlin Peter; Romaguera Jorge; Rodriguez Maria A; Cabanillas Fernando; Tiongson Lili Paz; Younes Anas
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(9):1818-21.
2006: Liu Qi; Fayad Luis; Cabanillas Fernando; Hagemeister Fredrick B; Ayers Gregory D; Hess Mark; Romaguera Jorge; Rodriguez M Alma; Tsimberidou Apostolia M; Verstovsek Srdan; Younes Anas; Pro Barbara; Lee Ming-Sheng; Ayala Ana; McLaughlin Peter
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1582-9.
2006: Thomas Deborah A; Faderl Stefan; O'Brien Susan; Bueso-Ramos Carlos; Cortes Jorge; Garcia-Manero Guillermo; Giles Francis J; Verstovsek Srdan; Wierda William G; Pierce Sherry A; Shan Jianqin; Brandt Mark; Hagemeister Fredrick B; Keating Michael J; Cabanillas Fernando; Kantarjian Hagop
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Cancer 2006;106(7):1569-80.
2006: Thomas Deborah A; Sarris Andreas H; Cortes Jorge; Faderl Stefan; O'Brien Susan; Giles Francis J; Garcia-Manero Guillermo; Rodriguez Maria A; Cabanillas Fernando; Kantarjian Hagop
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
Cancer 2006;106(1):120-7.
2005: Romaguera Jorge E; Fayad Luis; Rodriguez Maria A; Broglio Kristine R; Hagemeister Frederick B; Pro Barbara; McLaughlin Peter; Younes Anas; Samaniego Felipe; Goy Andre; Sarris Andreas H; Dang Nam H; Wang Michael; Beasley Virginia; Medeiros L Jeffrey; Katz Ruth L; Gagneja Harish; Samuels Barry I; Smith Terry L; Cabanillas Fernando F
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7013-23.
2005: Ha Chul S; Cabanillas Fernando; Lee Ming S; Tucker Susan L; McLaughlin Peter; Rodriguez Maria A; Younes Anas; Romaguera Jorge E; Mesina Ofelia M; Cox James D
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
International journal of radiation oncology, biology, physics 2005;63(1):188-93.
2005: Tsimberidou Apostolia-Maria; Younes Anas; Romaguera Jorge; Hagemeister Fredrick B; Rodriguez Maria A; Feng Lei; Ayala Ana; Smith Terry L; Cabanillas Fernando; McLaughlin Peter
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Cancer 2005;104(2):345-53.
2005: Hagemeister Fredrick; Cabanillas Fernando; Coleman Morton; Gregory Stephanie A; Zinzani Pier Luigi
The role of mitoxantrone in the treatment of indolent lymphomas.
The oncologist 2005;10(2):150-9.
2005: Goy Andre; Younes Anas; McLaughlin Peter; Pro Barbara; Romaguera Jorge E; Hagemeister Frederick; Fayad Luis; Dang Nam H; Samaniego Felipe; Wang Michael; Broglio Kristine; Samuels Barry; Gilles Frederic; Sarris Andreas H; Hart Susan; Trehu Elizabeth; Schenkein David; Cabanillas Fernando; Rodriguez Alma M
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):667-75.
2004: Visco Carlo; Vassilakopoulos Theodoros P; Kliche Kay Oliver; Nadali Gianpaolo; Viviani Simonetta; Bonfante Valeria; Medeiros L Jeffrey; Notti P; Rassidakis George Z; Peethambaram Prema; Wilder Richard; Witzig Thomas; Gianni Massimo; Bonadonna Gianni; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Leukemia & lymphoma 2004;45(10):2085-92.
2004: Thomas Deborah A; O'Brien Susan; Cortes Jorge; Giles Francis J; Faderl Stefan; Verstovsek Srdan; Ferrajoli Alessandra; Koller Charles; Beran Miloslav; Pierce Sherry; Ha Chul S; Cabanillas Fernando; Keating Michael J; Kantarjian Hagop
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma.
Blood 2004;104(6):1624-30.
2004: Younes Anas; Pro Barbara; Robertson Michael J; Flinn Ian W; Romaguera Jorge E; Hagemeister Fredrick; Dang Nam H; Fiumara Paolo; Loyer Evelyne M; Cabanillas Fernando F; McLaughlin Peter W; Rodriguez Maria Alma; Samaniego Felipe
Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5432-8.
2004: Goy Andre; Remache Yvonne K; Gu Jun; Stewart John; Hayes Kimberly J; Gold David; Jiang Yunfang; Barkoh Bedia A; Katz Ruth; Cabanillas Fernando; Gilles Frederic
Establishment and characterization of a new mantle cell lymphoma cell line M-1.
Leukemia & lymphoma 2004;45(6):1255-60.
2004: Popat U; Hosing C; Saliba R M; Anderlini P; van Besien K; Przepiorka D; Khouri I F; Gajewski J; Claxton D; Giralt S; Rodriguez M; Romaguera J; Hagemeister F; Ha C; Cox J; Cabanillas F; Andersson B S; Champlin R E
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;33(10):1015-23.
2004: Pro Barbara; Younes Anas; Albitar Maher; Dang Nam H; Samaniego Felipe; Romaguera Jorge; McLaughlin Peter; Hagemeister Fredrick B; Rodriguez Maria A; Clemons Marilyn; Cabanillas Fernando
Thalidomide for patients with recurrent lymphoma.
Cancer 2004;100(6):1186-9.
2004: Chronowski Gregory M; Wilder Richard B; Levy Larry B; Atkinson Edward N; Ha Chul S; Hagemeister Fredrick B; Barista Ibrahim; Rodriguez Maria A; Sarris Andreas H; Hess Mark A; Cabanillas Fernando; Cox James D
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
American journal of clinical oncology 2004;27(1):73-80.
2004: Ha Chul S; Lee Ming-Sheng; McLaughlin Peter; Tucker Susan L; Wilder Richard B; Cox James D; Cabanillas Fernando
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
Cancer journal (Sudbury, Mass.) 2004;10(1):49-53.
2003: Ha Chul S; Kong Joseph S; McLaughlin Peter; Tucker Susan L; Fayad Luis E; Hess Mark A; Wilder Richard B; Cabanillas Fernando; Cox James D
Stage III follicular lymphoma: long-term follow-up and patterns of failure.
International journal of radiation oncology, biology, physics 2003;57(3):748-54.
2003: Ha Chul S; Kong Joseph S; Tucker Susan L; McLaughlin Peter; Wilder Richard B; Hess Mark A; Cabanillas Fernando; Cox James D
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
International journal of radiation oncology, biology, physics 2003;57(2):316-20.
2003: Dabaja Bouthaina S; McLaughlin Peter; Ha Chul S; Pro Barbara; Meyers Christina A; Seabrooke Lee F; Wilder Richard B; Kyritsis Athanassios P; Preti H Alejandro; Yung W K Alfred; Levin Victor; Cabanillas Fernando; Cox James D
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Cancer 2003;98(5):1021-8.
2003: Dabaja Bouthaina S; Ha Chul S; Wilder Richard B; Pro Barbara; McLaughlin Peter; Cabanillas Fernando; Cox James D
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma.
Cancer journal (Sudbury, Mass.) 2003;9(4):321-4.
2003: Goy Andre; Ramdas Latha; Remache Yvonne K; Gu Jun; Fayad Luis; Hayes Kimberly J; Coombes Kevin R; Barkoh Bedia A; Katz Ruth; Ford Richard; Cabanillas Fernando; Gilles Frederic
Establishment and characterization by gene expression profiling of a new diffuse large B-cell lymphoma cell line, EJ-1, carrying t(14;18) and t(8;14) translocations.
Laboratory investigation; a journal of technical methods and pathology 2003;83(6):913-6.
2003: Rassidakis George Z; Goy Andre; Medeiros L Jeffrey; Jiang Yunfang; Thomaides Athanasios; Remache Yvonne; Cabanillas Fernando; Sarris Andreas H; Gilles Frederic
Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2213-20.
2003: Herling Marco; Rassidakis George Z; Medeiros L Jeffrey; Vassilakopoulos Theodoros P; Kliche Kay-Oliver; Nadali Gianpaolo; Viviani Simonetta; Bonfante Valeria; Giardini Roberto; Chilosi Marco; Kittas Christos; Gianni Alessandro M; Bonadonna Gianni; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2114-20.
2003: Seymour John F; Pro Barbara; Fuller Lillian M; Manning John T; Hagemeister Fredrick B; Romaguera Jorge; Rodriguez Maria A; Ha Chul S; Smith Terry L; Ayala Ana; Hess Mark; Cox James D; Cabanillas Fernando; McLaughlin Peter
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2115-22.
2003: Hosing C; Saliba R M; McLaughlin P; Andersson B; Rodriguez M A; Fayad L; Cabanillas F; Champlin R E; Khouri I F
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(5):737-44.
2003: Alexanian R; Weber D; Delasalle K; Cabanillas F; Dimopoulos M
Asymptomatic Waldenstrom's macroglobulinemia.
Seminars in oncology 2003;30(2):206-10.
2003: Romaguera Jorge E; Medeiros L Jeffrey; Hagemeister Frederick B; Fayad Luis E; Rodriguez Maria A; Pro Barbara; Younes Anas; McLaughlin Peter; Goy Andre; Sarris Andreas H; Dang Nan H; Samaniego Felipe; Brown H M; Gagneja Harish K; Cabanillas Fernando
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.
Cancer 2003;97(3):586-91.
2003: Chronowski Gregory M; Wilder Richard B; Tucker Susan L; Ha Chul S; Younes Anas; Fayad Luis; Rodriguez Maria A; Hagemeister Fredrick B; Barista Ibrahim; Cabanillas Fernando; Cox James D
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
International journal of radiation oncology, biology, physics 2003;55(1):36-43.
2002: Chronowski Gregory M; Wilder Richard B; Tucker Susan L; Ha Chul S; Sarris Andreas H; Hagemeister Fredrick B; Barista Ibrahim; Hess Mark A; Cabanillas Fernando; Cox James D
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Cancer 2002;95(12):2534-8.
2002: Rassidakis George Z; Medeiros L Jeffrey; Vassilakopoulos Theodoros P; Viviani Simonetta; Bonfante Valeria; Nadali Gianpaolo; Herling Marco; Angelopoulou Maria K; Giardini Roberto; Chilosi Marco; Kittas Christos; McDonnell Timothy J; Bonadonna Gianni; Gianni Alessandro M; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Blood 2002;100(12):3935-41.
2002: Tsimberidou Apostolia M; McLaughlin Peter; Younes Anas; Rodriguez Maria A; Hagemeister Fredrick B; Sarris Andreas; Romaguera Jorge; Hess Mark; Smith Terry L; Yang Ying; Ayala Ana; Preti Alejandro; Lee Ming-Sheng; Cabanillas Fernando
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Blood 2002;100(13):4351-7.
2002: Lee Hoon K; Wilder Richard B; Jones Dan; Ha Chul S; Pro Barbara; Rodriguez Maria A; Romaguera Jorge E; Cabanillas Fernando; Rodriguez Jose; Cox James D
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas.
Leukemia & lymphoma 2002;43(9):1769-75.
2002: Schlembach Pamela J; Wilder Richard B; Jones Dan; Ha Chul S; Fayad Luis E; Younes Anas; Hagemeister Fredrick; Hess Mark; Cabanillas Fernando; Cox James D
Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.
Cancer journal (Sudbury, Mass.) 2002;8(5):377-83.
2002: Rassidakis George Z; Jones Dan; Thomaides Athanasios; Sen Filiz; Lai Raymond; Cabanillas Fernando; McDonnell Timothy J; Medeiros L Jeffrey
Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections.
American journal of clinical pathology 2002;118(3):328-34.
2002: Tsimberidou Apostolia-Maria; Jiang Yunfang; Ford Richard J; Lichtiger Benjamin; Medeiros L Jeffrey; McLaughlin Peter; Cabanillas Fernando; Sarris Andreas H
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
Leukemia & lymphoma 2002;43(8):1589-98.
2002: Sarris A H; Phan A; Goy A; Romaguera J; Hagemeister F B; Rodriguez M A; McLaughlin P; Pro B; Medeiros L J; Samuels Barry; Mesina O; Bleyer A W; Cabanillas F
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.
Oncology (Williston Park, N.Y.) 2002;16(8 Suppl 7):27-31.
2002: Visco C; Medeiros L J; Jones D; Smith T; Rodriguez M A; McLaughlin P; Romaguera J; Cabanillas F; Sarris A H
Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1290-9.
2002: Wilder Richard B; Rodriguez Maria A; Medeiros L Jeffrey; Tucker Susan L; Ha Chul S; Romaguera Jorge E; Pro Barbara; Hess Mark A; Cabanillas Fernando; Cox James D
International prognostic index-based outcomes for diffuse large B-cell lymphomas.
Cancer 2002;94(12):3083-8.
2002: Sarris A H; Phan A; Duvic M; Romaguera J; McLaughlin P; Mesina O; King K; Medeiros L J; Rassidakis G Z; Samuels B; Cabanillas F
Trimetrexate in relapsed T-cell lymphoma with skin involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2876-80.
2002: Wilder Richard B; Schlembach Pamela J; Jones Dan; Chronowski Gregory M; Ha Chul S; Younes Anas; Hagemeister Fredrick B; Barista Ibrahim; Cabanillas Fernando; Cox James D
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Cancer 2002;94(6):1731-8.
2002: Rassidakis George Z; Medeiros L Jeffrey; Viviani Simonetta; Bonfante Valeria; Nadali Gian-Paolo; Vassilakopoulos Theodoros P; Mesina Ofelia; Herling Marco; Angelopoulou Maria K; Giardini Roberto; Chilosi Marco; Kittas Christos; McLaughlin Peter; Rodriguez M Alma; Romaguera Jorge; Bonadonna Gianni; Gianni Alessandro M; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: Barista I; Cabanillas F; Romaguera J E; Khouri I F; Yang Y; Smith T L; Strom S S; Medeiros L J; Hagemeister F B
Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):318-22.
2002: Wilder Richard B; Romaguera Jorge E; Tucker Susan L; Ha Chul S; Hess Mark A; Cabanillas Fernando; Cox James D
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma.
Cancer 2002;94(3):601-5.
2002: Sarris Andreas H; Jiang Yunfang; Tsimberidou Apostolia M; Thomaides Athanasios; Rassidakis George Z; Ford Richard J; Medeiros L Jeffrey; Cabanillas Fernando; McLaughlin Peter
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Seminars in oncology 2002;29(1 Suppl 2):48-55.
2002: Rassidakis George Z; Medeiros L Jeffrey; McDonnell Timothy J; Viviani Simonetta; Bonfante Valeria; Nadali Gianpaolo; Vassilakopoulos Theodoros P; Giardini Roberto; Chilosi Marco; Kittas Christos; Gianni Alessandro M; Bonadonna Gianni; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):488-93.
2002: Clodi Katharina; Asgari Zahra; Younes Mamoun; Palmer J Lynn; Cabanillas Fernando; Carbone Antonino; Andreeff Michael; Younes Anas
Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.
Cancer 2002;94(1):1-5.
2001: Khouri I F; Saliba R M; Giralt S A; Lee M S; Okoroji G J; Hagemeister F B; Korbling M; Younes A; Ippoliti C; Gajewski J L; McLaughlin P; Anderlini P; Donato M L; Cabanillas F F; Champlin R E
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Blood 2001;98(13):3595-9.
2001: Wilder R B; Jones D; Tucker S L; Fuller L M; Ha C S; McLaughlin P; Hess M A; Cabanillas F; Cox J D
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
International journal of radiation oncology, biology, physics 2001;51(5):1219-27.
2001: Fiumara P; Snell V; Li Y; Mukhopadhyay A; Younes M; Gillenwater A M; Cabanillas F; Aggarwal B B; Younes A
Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.
Blood 2001;98(9):2784-90.
2001: Page R D; Romaguera J E; Osborne B; Medeiros L J; Rodriguez J; North L; Sanz-Rodriguez C; Cabanillas F
Primary hepatic lymphoma: favorable outcome after combination chemotherapy.
Cancer 2001;92(8):2023-9.
2001: Aytac U; Claret F X; Ho L; Sato K; Ohnuma K; Mills G B; Cabanillas F; Morimoto C; Dang N H
Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint.
Cancer research 2001;61(19):7204-10.
2001: Herling M; Rassidakis G Z; Viviani S; Bonfante V; Giardini R; Gianni M; Morris S W; Cabanillas F; Medeiros L J; Sarris A H
Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients.
Leukemia & lymphoma 2001;42(5):969-79.
2001: Ha C S; Tucker S L; Blanco A I; Wilder R B; McLaughlin P; Cabanillas F; Cox J D
Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
Cancer 2001;92(5):1074-9.
2001: Rodriguez J; Munsell M; Yazji S; Hagemeister F B; Younes A; Andersson B; Giralt S; Gajewski J; de Lima M; Couriel D; Romaguera J; Cabanillas F F; Champlin R E; Khouri I F
Impact of high-dose chemotherapy on peripheral T-cell lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3766-70.
2001: Chronowski G M; Ha C S; Wilder R B; Cabanillas F; Manning J; Cox J D
Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
Cancer 2001;92(3):670-6.
2001: Rassidakis G Z; Sarris A H; Herling M; Ford R J; Cabanillas F; McDonnell T J; Medeiros L J
Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
The American journal of pathology 2001;159(2):527-35.
2001: Younes A; Preti H A; Hagemeister F B; McLaughlin P; Romaguera J E; Rodriguez M A; Samuels B I; Palmer J L; Cabanillas F
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):923-7.
2001: Sarris A H; Romaguera J; Hagemeister F B; Rodriguez M A; McLaughlin P; Pro B; Younes A; Mesina O; Cabanillas F; Medeiros L J; Samuels B
Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2001;15(7 Suppl 8):53-6.
2001: Ho L; Aytac U; Stephens L C; Ohnuma K; Mills G B; McKee K S; Neumann C; LaPushin R; Cabanillas F; Abbruzzese J L; Morimoto C; Dang N H
In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):2031-40.
2001: Liao Z; Ha C S; Vlachaki M T; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox J D
Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
International journal of radiation oncology, biology, physics 2001;50(4):971-7.
2001: Wilder R B; Rodriguez M A; Tucker S L; Ha C S; Hess M A; Cabanillas F F; Cox J D
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
International journal of radiation oncology, biology, physics 2001;50(3):743-9.
2001: Visco C; Medeiros L J; Mesina O M; Rodriguez M A; Hagemeister F B; McLaughlin P; Romaguera J E; Cabanillas F; Sarris A H
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
Clinical lymphoma 2001;2(1):40-6.
2001: Wilder R B; Rodriguez M A; Ha C S; Pro B; Hess M A; Cabanillas F; Cox J D
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Cancer 2001;91(12):2440-6.
2001: Tsimberidou A M; Sarris A H; Medeiros L J; Mesina O; Rodriguez M A; Hagemeister F B; Romaguera J; Pro B; McLaughlin P; Dang N; Cabanillas F
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Leukemia & lymphoma 2001;41(5-6):535-44.
2001: Pelloski C E; Wilder R B; Ha C S; Hess M A; Cabanillas F F; Cox J D
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;59(2):145-51.
2001: Rodriguez J; Romaguera J E; Katz R L; Said J; Cabanillas F
Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus.
Leukemia & lymphoma 2001;41(1-2):185-9.
2001: Ha C S; Tucker S L; Lee M S; McLaughlin P; Cabanillas F; Cox J D
The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
International journal of radiation oncology, biology, physics 2001;49(3):727-32.
2001: Ha C S; Shadle K M; Medeiros L J; Wilder R B; Hess M A; Cabanillas F; Cox J D
Localized non-Hodgkin lymphoma involving the thyroid gland.
Cancer 2001;91(4):629-35.
2001: Sarris A H; Braunschweig I; Medeiros L J; Duvic M; Ha C S; Rodriguez M A; Hagemeister F B; McLaughlin P; Romaguera J; Cox J; Cabanillas F
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):398-405.
2001: Wilder R B; Tucker S L; Ha C S; Rodriguez M A; Hess M A; Cabanillas F F; Cox J D
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
International journal of radiation oncology, biology, physics 2001;49(1):17-22.
2000: Younes A; Cristofanilli M; McLaughlin P; Hagemeister F B; Weber D; Mesina O; Cabanillas F
Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma.
Leukemia & lymphoma 2000;40(1-2):79-85.
2000: McLaughlin P; Hagemeister F B; Rodriguez M A; Sarris A H; Pate O; Younes A; Lee M S; Dang N H; Romaguera J E; Preti A H; McAda N; Cabanillas F
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.
Seminars in oncology 2000;27(6 Suppl 12):37-41.
2000: Rodriguez J; McLaughlin P; Fayad L; Santiago M; Hess M; Rodriguez M A; Romaguera J; Hagemeister F; Kantarjian H; Cabanillas F
Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1551-6.
2000: Schlembach P J; Wilder R B; Tucker S L; Ha C S; Rodriguez M A; Hess M A; Cabanillas F F; Cox J D
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
International journal of radiation oncology, biology, physics 2000;48(4):1107-10.
2000: Sarris A H; Psyrri A; Hagemeister F; Romaguera J; McLaughlin P; Rodriguez M A; Bachier C; Younes A; Mesina O; Oholendt M; Medeiros L J; Samuels B; Adams L M; Cabanillas F
Infusional vinorelbine in relapsed or refractory lymphomas.
Leukemia & lymphoma 2000;39(3-4):291-9.
2000: Anderlini P; Giralt S; Andersson B; Ueno N T; Khouri I; Acholonu S; Cohen A; Körbling M J; Manning J; Romaguera J; Sarris A; Rodriguez; Hagemeister F; Mclaughlin P; Cabanillas F; Champlin R E
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
Bone marrow transplantation 2000;26(6):615-20.
2000: Rodriguez J; Romaguera J E; Manning J; Ordonez N; Ha C; Ravandi F; Cabanillas F
Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases.
Leukemia & lymphoma 2000;39(1-2):139-44.
2000: Romaguera J E; Khouri I F; Kantarjian H M; Hagemeister F B; Rodriguez M A; McLaughlin P; Sarris A H; Younes A; Rodriguez J; Cabanillas F
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients.
Leukemia & lymphoma 2000;39(1-2):77-85.
2000: Liao Z; Ha C S; McLaughlin P; Manning J T; Hess M; Cabanillas F; Cox J D
Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.
International journal of radiation oncology, biology, physics 2000;48(2):399-403.
2000: Katz R L; Caraway N P; Gu J; Jiang F; Pasco-Miller L A; Glassman A B; Luthra R; Hayes K J; Romaguera J E; Cabanillas F F; Medeiros L J
Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma.
American journal of clinical pathology 2000;114(2):248-57.
2000: Nguyen L N; Ha C S; Hess M; Romaguera J E; Manning J T; Cabanillas F; Cox J D
The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.
International journal of radiation oncology, biology, physics 2000;47(5):1281-5.
2000: Verstovsek S; Cabanillas F; Dang N H
CD26 in T-cell lymphomas: a potential clinical role?
Oncology (Williston Park, N.Y.) 2000;14(6 Suppl 2):17-23.
2000: Cabanillas F
Purine nucleoside analogs in indolent non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2000;14(6 Suppl 2):13-5.
2000: Sarris A H; Hagemeister F; Romaguera J; Rodriguez M A; McLaughlin P; Tsimberidou A M; Medeiros L J; Samuels B; Pate O; Oholendt M; Kantarjian H; Burge C; Cabanillas F
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):69-72.
2000: López-Guillermo A; Cabanillas F; McLaughlin P; Smith T; Hagemeister F; Rodríguez M A; Romaguera J E; Younes A; Sarris A H; Preti H A; Pugh W; Lee M S
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():137-40.
1999: Ha C S; Tucker S L; Blanco A I; Cabanillas F; Cox J D
Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.
International journal of radiation oncology, biology, physics 1999;45(5):1207-12.
1999: Khouri I F; Lee M S; Romaguera J; Mirza N; Kantarjian H; Korbling M; Albitar M; Giralt S; Samuels B; Anderlini P; Rodriguez J; von Wolff B; Gajewski J; Cabanillas F; Champlin R
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1293-9.
1999: Donato M L; Champlin R E; Van Besien K W; Korbling M; Cabanillas F; Anderlini P; Gajewski J G; Lauppe J; Durett A; Andersson B; Giralt S; Khouri I; Hagemeister F; Romaguera J E; Sarris A; McLaughlin P; Younes A; Ippoliti C; Blamble D A; Hester J; Gee A; Rodriguez M A
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
1999: Cabanillas F
The role of topoisomerase-I inhibitors in the treatment of non-Hodgkin's lymphoma.
Seminars in hematology 1999;36(4 Suppl 8):11-5.
1999: Luthra R; Sarris A H; Hai S; Paladugu A V; Romaguera J E; Cabanillas F F; Medeiros L J
Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32).
American journal of clinical pathology 1999;112(4):524-30.
1999: Thomas D A; Cortes J; O'Brien S; Pierce S; Faderl S; Albitar M; Hagemeister F B; Cabanillas F F; Murphy S; Keating M J; Kantarjian H
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2461-70.
1999: Ayoub J P; Palmer J L; Huh Y; Cabanillas F; Younes A
Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease.
Leukemia & lymphoma 1999;34(5-6):519-27.
1999: Steinbach G; Ford R; Glober G; Sample D; Hagemeister F B; Lynch P M; McLaughlin P W; Rodriguez M A; Romaguera J E; Sarris A H; Younes A; Luthra R; Manning J T; Johnson C M; Lahoti S; Shen Y; Lee J E; Winn R J; Genta R M; Graham D Y; Cabanillas F F
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Annals of internal medicine 1999;131(2):88-95.
1999: Rodriguez J; Rodriguez M A; Fayad L; McLaughlin P; Swan F; Sarris A; Romaguera J; Andersson B; Cabanillas F; Hagemeister F B
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.
Blood 1999;93(11):3632-6.
1999: López-Guillermo A; Cabanillas F; McDonnell T I; McLaughlin P; Smith T; Pugh W; Hagemeister F; Rodríguez M A; Romaguera J E; Younes A; Sarris A H; Preti H A; Lee M S
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
Blood 1999;93(9):3081-7.
1999: Sarris A H; Kliche K O; Pethambaram P; Preti A; Tucker S; Jackow C; Messina O; Pugh W; Hagemeister F B; McLaughlin P; Rodriguez M A; Romaguera J; Fritsche H; Witzig T; Duvic M; Andreeff M; Cabanillas F
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):433-40.
1999: Logsdon M D; Meyn R E; Besa P C; Pugh W C; Stephens L C; Peters L J; Milas L; Cox J D; Cabanillas F; Brisbay S; Andersen M; McDonnell T J
Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.
International journal of radiation oncology, biology, physics 1999;44(1):19-29.
1999: Ha C S; Cho M J; Allen P K; Fuller L M; Cabanillas F; Cox J D
Primary non-Hodgkin lymphoma of the small bowel.
Radiology 1999;211(1):183-7.
1999: Rodriguez J; McLaughlin P; Hagemeister F B; Fayad L; Rodriguez M A; Santiago M; Hess M; Romaguera J; Cabanillas F
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Blood 1999;93(7):2202-7.
1999: Oh Y K; Ha C S; Samuels B I; Cabanillas F; Hess M A; Cox J D
Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies.
Radiology 1999;210(2):483-6.
1999: Bachier C R; Giles R E; Ellerson D; Hanania E G; Garcia-Sanchez F; Andreeff M; Cabanillas F; Champlin R; Choudhury R; Berenson R; Heimfeld S; Deisseroth A B
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;32(3-4):279-88.
1999: Ha C S; Kavadi V; Dimopoulos M A; Hagemeister F B; Osborne B M; Fuller L M; Smith T L; Hess M A; McLaughlin P W; Cabanillas F F; Cox J D
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
International journal of radiation oncology, biology, physics 1999;43(2):329-34.
1999: Romaguera J E; Rodriguez M A; Hagemeister F B; McLaughlin P; Rodriguez J; Preti A; Younes A; Sarris A H; Cabanillas F
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination.
Investigational new drugs 1999;17(2):187-92.
1998: Romaguera J E; Hagemeister F B; McLaughlin P; Rodriguez M A; Bachier C; Preti H; Sarris A H; Weber D; Younes A; Cabanillas F
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
Leukemia & lymphoma 1998;32(1-2):97-106.
1998: Younes A; Romaguera J; Mesina O; Hagemeister F; Sarris A H; Rodriguez M A; McLaughlin P; Preti H A; Bachier C; Cabanillas F
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma.
British journal of haematology 1998;103(3):678-83.
1998: Khouri I F; Romaguera J; Kantarjian H; Palmer J L; Pugh W C; Korbling M; Hagemeister F; Samuels B; Rodriguez A; Giralt S; Younes A; Przepiorka D; Claxton D; Cabanillas F; Champlin R
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3803-9.
1998: Clodi K; Asgary Z; Zhao S; Kliche K O; Cabanillas F; Andreeff M; Younes A
Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells.
British journal of haematology 1998;103(1):270-5.
1998: Clodi K; Snell V; Zhao S; Cabanillas F; Andreeff M; Younes A
Unbalanced expression of Fas and CD40 in mantle cell lymphoma.
British journal of haematology 1998;103(1):217-9.
1998: Vlachaki M T; Ha C S; Hagemeister F B; Fuller L M; Rodriguez M A; Hess M A; Tucker S L; Cabanillas F; Cox J D
Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997.
Radiology 1998;208(3):739-47.
1998: Fayad L; Cabanillas F; Talpaz M; McLaughlin P; Kurzrock R
High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma.
Leukemia & lymphoma 1998;30(5-6):563-71.
1998: Ha C S; Dubey P; Goyal L K; Hess M; Cabanillas F; Cox J D
Localized primary non-Hodgkin lymphoma of the breast.
American journal of clinical oncology 1998;21(4):376-80.
1998: McLaughlin P; Grillo-López A J; Link B K; Levy R; Czuczman M S; Williams M E; Heyman M R; Bence-Bruckler I; White C A; Cabanillas F; Jain V; Ho A D; Lister J; Wey K; Shen D; Dallaire B K
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2825-33.
1998: Liao Z; Ha C S; Fuller L M; Hagemeister F B; Cabanillas F; Tucker S L; Hess M A; Cox J D
Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
International journal of radiation oncology, biology, physics 1998;41(5):1047-56.
1998: Tormo M; Tari A M; McDonnell T J; Cabanillas F; Garcia-Conde J; Lopez-Berestein G
Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation.
Leukemia & lymphoma 1998;30(3-4):367-79.
1998: Luthra R; McBride J A; Cabanillas F; Sarris A
Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma.
The American journal of pathology 1998;153(1):63-8.
1998: Maor M H; North L B; Cabanillas F F; Ames A L; Hess M A; Cox J D
Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma.
International journal of radiation oncology, biology, physics 1998;41(3):647-50.
1998: Cabanillas F; Rodriguez-Diaz Pavón J; Hagemeister F B; McLaughlin P; Rodriguez M A; Romaguera J E; Dong K; Moon T
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):511-8.
1998: Sarris A H; Luthra R; Cabanillas F; Morris S W; Pugh W C
Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
Leukemia & lymphoma 1998;29(5-6):507-14.
1998: Daliani D; Ulmer R A; Jackow C; Pugh W; Gansbacher B; Cabanillas F; Duvic M; Sarris A H
Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.
Leukemia & lymphoma 1998;29(3-4):315-28.
1998: Herrada J; Cabanillas F; Rice L; Manning J; Pugh W
The clinical behavior of localized and multicentric Castleman disease.
Annals of internal medicine 1998;128(8):657-62.
1998: López-Guillermo A; Cabanillas F; McLaughlin P; Smith T; Hagemeister F; Rodríguez M A; Romaguera J E; Younes A; Sarris A H; Preti H A; Pugh W; Lee M S
The clinical significance of molecular response in indolent follicular lymphomas.
Blood 1998;91(8):2955-60.
1998: Hughes J H; Katz R L; Fonseca G A; Cabanillas F F
Fine-needle aspiration cytology of mediastinal non-Hodgkin's nonlymphoblastic lymphoma.
Cancer 1998;84(1):26-35.
1998: van Besien K; Ha C S; Murphy S; McLaughlin P; Rodriguez A; Amin K; Forman A; Romaguera J; Hagemeister F; Younes A; Bachier C; Sarris A; Sobocinski K S; Cox J D; Cabanillas F
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
Blood 1998;91(4):1178-84.
1998: Romaguera J E; Rodríguez Díaz-Pavon J; Carías L; Hagemeister F B; McLaughlin P; Rodríguez M A; Sarris A H; Younes A; Preti A; Bachier C; Llerena E; Cabanillas F
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients.
Leukemia & lymphoma 1998;28(3-4):295-306.
1998: Fuller L M; Mirza N Q; Palmer J L; Davis B R; Ha C S; Rodriguez M A; Hagemeister F B; Cabanillas F; McLaughlin P; Butler J J; North L B; Martin R G
Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II.
International journal of radiation oncology, biology, physics 1998;40(2):377-86.
1998: Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):63-9.
1998: Luthra R; Pugh W C; Waasdorp M; Morris W; Cabanillas F; Chan P K; Sarris A H
Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Hematopathology and molecular hematology 1998;11(3-4):173-83.
1997: Cabanillas F
Can we cure indolent lymphomas?
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2655-9.
1997: Keating M J; McLaughlin P; Cabanillas F
Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).
European journal of cancer care 1997;6(4 Suppl):21-6.
1997: Snell V; Clodi K; Zhao S; Goodwin R; Thomas E K; Morris S W; Kadin M E; Cabanillas F; Andreeff M; Younes A
Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies.
British journal of haematology 1997;99(3):618-24.
1997: Meistrich M L; Wilson G; Mathur K; Fuller L M; Rodriguez M A; McLaughlin P; Romaguera J E; Cabanillas F F; Ha C S; Lipshultz L I; Hagemeister F B
Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3488-95.
1997: Munker R; Younes A; Cabanillas F; Andreeff M
Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: absence of prognostic correlations.
Leukemia & lymphoma 1997;27(5-6):517-21.
1997: Younes A; Consoli U; Snell V; Clodi K; Kliche K O; Palmer J L; Gruss H J; Armitage R; Thomas E K; Cabanillas F; Andreeff M
CD30 ligand in lymphoma patients with CD30+ tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3355-62.
1997: Cho M J; Ha C S; Allen P K; Fuller L M; Cabanillas F; Cox J D
Primary non-Hodgkin lymphoma of the large bowel.
Radiology 1997;205(2):535-9.
1997: Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford R J
Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(10):1071-82.
1997: Rodriguez-Monge E J; Cabanillas F
Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience.
Hematology/oncology clinics of North America 1997;11(5):937-47.
1997: Vlachaki M T; Ha C S; Hagemeister F B; Fuller L M; Rodriguez M A; Besa P C; Hess M A; Brown B; Cabanillas F; Cox J D
Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
International journal of radiation oncology, biology, physics 1997;39(3):609-16.
1997: Clodi K; Younes A; Goodacre A; Roberts M; Palmer J; Younes M; Cabanillas F; Andreeff M
Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridization.
British journal of haematology 1997;98(4):913-21.
1997: van Besien K; Thall P; Korbling M; Pugh W C; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):150-6.
1997: Preti H A; Cabanillas F; Talpaz M; Tucker S L; Seymour J F; Kurzrock R
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma.
Annals of internal medicine 1997;127(3):186-94.
1997: Logsdon M D; Ha C S; Kavadi V S; Cabanillas F; Hess M A; Cox J D
Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
Cancer 1997;80(3):477-88.
1997: Younes A; Rodriguez M A; McLaughlin P; North L; Sarris A H; Pate O; Hagemeister F B; Romaguera J; Preti A; Bachier C; Cabanillas F
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1997;26(1-2):77-82.
1997: Sarris A H; Papadimitrakopoulou V; Dimopoulos M A; Smith T; Pugh W; Ha C S; McLaughlin P; Callender D; Cox J; Cabanillas F
Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
Leukemia & lymphoma 1997;26(1-2):49-56.
1997: Vlachaki M T; Hagemeister F B; Fuller L M; Besa P C; Hess M A; Brown B; Cabanillas F; Cox J D
Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
International journal of radiation oncology, biology, physics 1997;38(3):593-9.
1997: Ayoub J P; North L; Greer J; Cabanillas F; Younes A
Pulmonary changes in patients with lymphoma who receive paclitaxel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2476.
1997: Majlis A; Pugh W C; Rodriguez M A; Benedict W F; Cabanillas F
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1664-71.
1997: Luthra R; McBride J A; Hai S; Cabanillas F; Pugh W C
The application of fluorescence-based PCR and PCR-SSCP to monitor the clonal relationship of cells bearing the t(14;18)(q32;q21) in sequential biopsy specimens from patients with follicle center cell lymphoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1997;6(2):71-7.
1997: Dubey P; Ha C S; Besa P C; Fuller L; Cabanillas F; Murray J; Hess M A; Cox J D
Localized primary malignant lymphoma of bone.
International journal of radiation oncology, biology, physics 1997;37(5):1087-93.
1997: Dimopoulos M A; Daliani D; Pugh W; Gershenson D; Cabanillas F; Sarris A H
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy.
Gynecologic oncology 1997;64(3):446-50.
1997: Ha C S; Cabanillas F; Lee M S; Besa P C; McLaughlin P; Cox J D
Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):215-9.
1997: Sarris A H; Daliani D; Ulmer R; Crow M; Broxmeyer H E; Reiss M; Karasavvas N; Zelenetz A D; Pugh W; Cabanillas F; Deisseroth A B; Duvic M
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):169-77.
1997: Younes A; Ayoub J P; Sarris A; Hagemeister F; North L; Pate O; McLaughlin P; Rodriguez M A; Romaguera J; Kurzrock R; Preti A; Bachier C; Smith T; Cabanillas F
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.
British journal of haematology 1997;96(2):328-32.
1997: Herrada J; Phillips D K; Hebert A A; Cabanillas F; Jordon R E
A progressive blistering eruption in a patient with lymphoma. Paraneoplastic pemphigus.
Archives of dermatology 1997;133(1):97, 100-1.
1997: Younes A; Zhao S; Zhang X; Snell V; Clodi K; Kliche K O; Thomas E; Cabanillas F; Andreeff M
CD30-ligand and CD40-ligand expression in lymph nodes involved with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():97-100.
1997: Sarris A H; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos M A; McBride J A; Cabanillas F; Duvic M; Deisseroth A; Morris S W; Pugh W C
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():59-63.
1997: Younes A; Ayoub J P; Sarris A; North L; Pate O; McLaughlin P; Rodriguez M A; Romaguera J; Hagemeister F; Bachier C; Preti A; Cabanillas F
Paclitaxel (Taxol) for the treatment of lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():129-31.
1996: Sarris A H; Daliani D; Ulmer R; Crow M; Broxmeyer H E; Pugh W; Reiss M; Cabanillas F; Deisseroth A B; Duvic M
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas.
Leukemia & lymphoma 1996;24(1-2):103-10.
1996: Younes A; Cabanillas F; McLaughlin P W; Hagemeister F B; Farber C; Sarris A; Pate O; Myers J; Portlock C
Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(10):1083-5.
1996: Romaguera J E; Meilus S; Rodriguez J; Brooks T; Ordonez N; Cabanillas F
Endocrine characterization of primary mediastinal lymphoma.
Leukemia & lymphoma 1996;23(5-6):613-5.
1996: Fayad L; Robertson L E; O'Brien S; Manning J T; Wright S; Hagemeister F; Cabanillas F; Keating M J
Hodgkin's disease variant of Richter's syndrome: experience at a single institution.
Leukemia & lymphoma 1996;23(3-4):333-7.
1996: Sarris A H; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos M A; McBride J A; Cabanillas F; Duvic M; Deisseroth A; Morris S W; Pugh W C
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Blood 1996;88(5):1771-9.
1996: Younes A; Consoli U; Zhao S; Snell V; Thomas E; Gruss H J; Cabanillas F; Andreeff M
CD30 ligand is expressed on resting normal and malignant human B lymphocytes.
British journal of haematology 1996;93(3):569-71.
1996: Duvic M; Lemak N A; Redman J R; Eifel P J; Tucker S L; Cabanillas F F; Kurzrock R
Combined modality therapy for cutaneous T-cell lymphoma.
Journal of the American Academy of Dermatology 1996;34(6):1022-9.
1996: Estey E; Thall P F; Mehta K; Rosenblum M; Brewer T; Simmons V; Cabanillas F; Kurzrock R; Lopez-Berestein G
Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid.
Blood 1996;87(9):3650-4.
1996: McLaughlin P; Hagemeister F B; Romaguera J E; Sarris A H; Pate O; Younes A; Swan F; Keating M; Cabanillas F
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1262-8.
1996: Younes A; Sarris A; Consoli U; Rodriguez A; McLaughlin P; Huh Y; Starry S; Cabanillas F; Andreeff M
A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results.
Blood 1996;87(5):1698-703.
1996: van Besien K W; Mehra R C; Giralt S A; Kantarjian H M; Pugh W C; Khouri I F; Moon Y; Williams P; Andersson B S; Przepiorka D; McCarthy P L; Gajewski J L; Deisseroth A B; Cabanillas F F; Champlin R
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
The American journal of medicine 1996;100(3):299-307.
1996: Seymour J F; McLaughlin P; Fuller L M; Hagemeister F B; Hess M; Swan F; Romaguera J; Rodriguez M A; Besa P; Cox J; Cabanillas F
High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):157-63.
1996: Younes A; Ayoub J P; Hagemeister F B; McLaughlin P; Sarris A; Rodriguez M A; Swan F; Romaguera J E; Martin J; Cabanillas F
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):543-8.
1996: McBride J A; Rodriguez J; Luthra R; Ordóñez N G; Cabanillas F; Pugh W C
T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease.
The American journal of surgical pathology 1996;20(2):193-201.
1996: Sarris A H; Younes A; McLaughlin P; Moore D; Hagemeister F; Swan F; Rodriguez M A; Romaguera J; North L; Mansfield P; Callendar D; Mesina O; Cabanillas F
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):233-9.
1995: Romaguera J E; Garcia-Foncillas J; Cabanillas F
16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
Leukemia & lymphoma 1995;20(1-2):97-102.
1995: Ford R; Tamayo A; Martin B; Niu K; Claypool K; Cabanillas F; Ambrus J
Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas.
Blood 1995;86(1):283-93.
1995: Symmans W F; Katz R L; Ordoñez N G; Dalton H; Romaguera J E; Cabanillas F
Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.
Acta cytologica 1995;39(4):673-82.
1995: Jendiroba D; Younes A; Katz R; Hill D; Cabanillas F; Andreeff M
Chromosome 17 numerical abnormalities in 55 patients with non-Hodgkin's lymphoma: a fluorescence in situ hybridization study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(7):1144-6.
1995: Younes A; Jendiroba D; Katz R; Hill D; Cabanillas F; Andreeff M
Chromosome X numerical abnormalities in patients with non-Hodgkin's lymphoma. A study of 59 patients using fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1995;82(1):23-9.
1995: Sarris A; Dimopoulos M; Pugh W; Cabanillas F
Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy.
The Journal of urology 1995;153(6):1852-4.
1995: Touroutoglou N; Dimopoulos M A; Younes A; Hess M; Pugh W; Cox J; Cabanillas F; Sarris A H
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1361-7.
1995: Younes A; Zhao S; Jendiroba D; Kleine H D; Cabanillas F; Andreeff M
Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphoma.
Blood 1995;85(10):2813-6.
1995: Stroh E L; Besa P C; Cox J D; Fuller L M; Cabanillas F F
Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy.
Cancer 1995;75(9):2392-9.
1995: Sarris A H; Majlis A; Dimopoulos M A; Younes A; Swann F; Rodriguez M A; McLaughlin P; Cabanillas F
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma.
Leukemia & lymphoma 1995;17(5-6):473-7.
1995: Cortes J E; Talpaz M; Cabanillas F; Seymour J F; Kurzrock R
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.
Blood 1995;85(9):2516-20.
1995: Herrada J; Cabanillas F F
Multicentric Castleman's disease.
American journal of clinical oncology 1995;18(2):180-3.
1995: Seymour J F; Talpaz M; Cabanillas F; Wetzler M; Kurzrock R
Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):575-82.
1995: Diaz-Pavon J R; Pugh W; Cabanillas F
Simultaneous presentation of hairy cell leukemia and follicular small cleaved cell lymphoma in a patient with previous diagnosis of renal cell carcinoma.
Hematological oncology 1995;13(2):63-7.
1995: Cabanillas F; Armitage J; Pugh W C; Weisenburger D; Duvic M
Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma.
Annals of internal medicine 1995;122(3):210-7.
1995: Diaz-Pavon J R; Cabanillas F; Majlis A; Hagemeister F B
Outcome of Hodgkin's disease in elderly patients.
Hematological oncology 1995;13(1):19-27.
1995: Fuller L M; Krasin M J; Velasquez W S; Allen P K; McLaughlin P; Rodriguez M A; Hagemeister F B; Swan F; Cabanillas F; Palmer J L
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.
International journal of radiation oncology, biology, physics 1995;31(1):3-11.
1995: Moore D F; Swan F; Yau J; Rodriguez M A; McLaughlin P; Sarris A; Romaguera J; Younes A; Hagemeister F B; Cabanillas F
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1995;7(5):300-3.
1994: Dimopoulos M A; Kantarjian H; Weber D; O'Brien S; Estey E; Delasalle K; Rose E; Cabanillas F; Keating M; Alexanian R
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2694-8.
1994: Rodriguez J; Pugh W C; Romaguera J E; Luthra R; Hagemeister F B; McLaughlin P; Rodriguez M A; Swan F; Cabanillas F
Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):847-9.
1994: Younes A; Jendiroba D; Engel H; Escudier S; Katz R; Rodriguez M A; Hill D; Cabanillas F; Andreeff M
High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement.
Cancer genetics and cytogenetics 1994;77(1):39-44.
1994: Rodriguez J; Pugh W C; Romaguera J E; Cabanillas F
Primary mediastinal large cell lymphoma.
Hematological oncology 1994;12(4):175-84.
1994: Velasquez W S; McLaughlin P; Tucker S; Hagemeister F B; Swan F; Rodriguez M A; Romaguera J; Rubenstein E; Cabanillas F
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1169-76.
1994: Velasquez W S; McLaughlin P; Fuller L M; Allen P K; Tucker S L; Swan F; Rodriguez M A; Hagemeister F B; Cabanillas F F
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Cancer 1994;73(9):2408-16.
1994: Romaguera J E; Manning J T; Tornos C S; Rodriguez J; Brooks T E; Pugh W C; Ordonez N G; Goodacre A M; Cabanillas F
Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(4):317-22.
1994: Hagemeister F B; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Seminars in hematology 1994;31(2 Suppl 3):36-43.
1994: Cabanillas F; Rodriguez M A
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
Seminars in hematology 1994;31(2 Suppl 3):30.
1994: McLaughlin P; Hagemeister F B; Swan F; Cabanillas F; Pate O; Romaguera J E; Rodriguez M A; Redman J R; Keating M
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):575-9.
1994: Younes A; Pugh W; Goodacre A; Katz R; Rodriguez M A; Hill D; Cabanillas F; Andreeff M
Polysomy of chromosome 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphoma.
Genes, chromosomes & cancer 1994;9(3):161-7.
1994: Younes A; Drach J; Katz R; Jendiroba D; Sabourian M H; Sarris A H; Swan F; Hill D; Cabanillas F; Ford R
Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):265-8.
1994: Seymour J F; Younes A; Cabanillas F
Lymphomatous presentation of CD4+/CD8+ HTLV-1-related adult T-cell leukemia/lymphoma in an Iranian woman.
Leukemia & lymphoma 1994;12(5-6):471-6.
1994: Keating M J; O'Brien S; Plunkett W; Robertson L E; Gandhi V; Estey E; Dimopoulos M; Cabanillas F; Kemena A; Kantarjian H
Fludarabine phosphate: a new active agent in hematologic malignancies.
Seminars in hematology 1994;31(1):28-39.
1994: Keating M J; McLaughlin P; Plunkett W; Robertson L E; O'Brien S; Gandhi V; Gregoire V; Yang L; Cabanillas F
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():79-83.
1994: Hagemeister F B; Purugganan R; Podoloff D A; Hess M; Rodriguez M A; McLaughlin P; Swan F; Romaguera J E; Cabanillas F
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():59-63.
1994: Hagemeister F B; Khetan R; Allen P; McLaughlin P; Rodriguez M A; Swan F; Romaguera J E; Cabanillas F
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():41-6.
1994: Romaguera J E; Rodriguez M A; Hagemeister F B; McLaughlin P; Swan F; Moore D F; Sarris A H; Younes A; Hill D; Cabanillas F
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Investigational new drugs 1994;12(3):217-22.
1994: Keating M J; O'Brien S; Robertson L E; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Li Y Y; Gandhi V
The expanding role of fludarabine in hematologic malignancies.
Leukemia & lymphoma 1994;14 Suppl 2():11-6.
1994: Preti A; Hagemeister F B; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox J D; Allen P K; Cabanillas F
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():97-100.
1994: McLaughlin P; Hagemeister F B; Swan F; Cabanillas F; Romaguera J; Rodriguez M A; Lee M S; Pate O; Sarris A; Younes A
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():73-7.
1993: Robertson L E; Pugh W; O'Brien S; Kantarjian H; Hirsch-Ginsberg C; Cork A; McLaughlin P; Cabanillas F; Keating M J
Richter's syndrome: a report on 39 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1985-9.
1993: Moore D F; Cabanillas F
What constitutes a "cure" in lymphoma?
Leukemia & lymphoma 1993;11(3-4):161-3.
1993: Keating M J; O'Brien S; Robertson L E; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Yang L Y; Gandhi V
New initiatives with fludarabine monophosphate in hematologic malignancies.
Seminars in oncology 1993;20(5 Suppl 7):13-20.
1993: Rodriguez J; Pugh W C; Cabanillas F
T-cell-rich B-cell lymphoma.
Blood 1993;82(5):1586-9.
1993: Dimopoulos M A; Cabanillas F; Lee J J; Swan F; Fuller L; Allen P K; Hagemeister F B
Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1108-11.
1993: Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Cancer research 1993;53(9):2118-22.
1993: Liang J C; Bailey N M; Gabriel G J; Kattan M W; Wang R Y; Hagemeister F B; Cabanillas F F; Fuller L M
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Leukemia & lymphoma 1993;9(6):503-8.
1993: McLaughlin P; Cabanillas F; Hagemeister F B; Swan F; Romaguera J E; Taylor S; Rodriguez M A; Velasquez W S; Redman J R; Gutterman J U
CHOP-Bleo plus interferon for stage IV low-grade lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(3):205-11.
1993: Spinolo J A; Jagannath S; Velásquez W; Spitzer G; Cabanillas F; Hagemeister F; Horwitz L J; Dicke K A
Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's disease.
Leukemia & lymphoma 1993;9(1-2):71-7.
1993: Romaguera J E; Pugh W; Luthra R; Goodacre A; Cabanillas F
The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(1):51-4.
1993: Soubeyran P; Cabanillas F; Lee M S
Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphomas.
Blood 1993;81(1):122-7.
1993: Ford R J; Tamayo A; Li D J; Cabanillas F
Human B cell lymphomas: in vitro and in vivo studies on growth factors and cell growth.
Leukemia & lymphoma 1993;10 Suppl():51-6.
1993: Rodriguez J; Pugh W; Romaguera J; Cabanillas F
Anaplastic Ki-1 + large-cell lymphoma.
Cancer investigation 1993;11(5):554-8.
1992: Hagemeister F B; Fuller L; McLaughlin P; Rodriguez M; Romaguera J; Swan F; Cabanillas F
NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():87-90.
1992: Redman J R; Cabanillas F; Velasquez W S; McLaughlin P; Hagemeister F B; Swan F; Rodriguez M A; Plunkett W K; Keating M J
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):790-4.
1992: Spinolo J A; Cabanillas F; Dixon D O; Khorana S M; McLaughlin P; Velasquez W S; Hagemeister F B; Redman J R; Swan F
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(3):227-32.
1992: Rolston K V; Berkey P; Bodey G P; Anaissie E J; Khardori N M; Joshi J H; Keating M J; Holmes F A; Cabanillas F F; Elting L
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
Archives of internal medicine 1992;152(2):283-91.
1992: Cabanillas F; Velasquez W S; Hagemeister F B; McLaughlin P; Redman J R
Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma.
Blood 1992;79(4):1024-8.
1992: Cabanillas F
Non-Hodgkin's lymphomas: a review of the M.D. Anderson experience.
Seminars in oncology 1992;19(1 Suppl 1):11-3.
1992: Woo S Y; Fuller L M; Cundiff J H; Bondy M L; Hagemeister F B; McLaughlin P; Velasquez W S; Swan F; Rodriguez M A; Cabanillas F
Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease.
International journal of radiation oncology, biology, physics 1992;23(2):407-12.
1991: Rodriguez M A; Ford R J; Goodacre A; Selvanayagam P; Cabanillas F; Deisseroth A B
Chromosome 17- and p53 changes in lymphoma.
British journal of haematology 1991;79(4):575-82.
1991: Litam P; Swan F; Cabanillas F; Tucker S L; McLaughlin P; Hagemeister F B; Rodriguez M A; Velasquez W S
Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.
Annals of internal medicine 1991;114(10):855-60.
1991: Romaguera J E; McLaughlin P; North L; Dixon D; Silvermintz K B; Garnsey L A; Velasquez W S; Hagemeister F B; Cabanillas F
Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):762-9.
1991: Kornblau S M; Goodacre A; Cabanillas F
Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature.
Hematological oncology 1991;9(2):63-78.
1991: McLaughlin P; Fuller L; Redman J; Hagemeister F; Durr E; Allen P; Holmes L; Velasquez W; Swan F; Cabanillas F
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():137-40.
1990: Hagemeister F B; Cabanillas F; Velásquez W S; Meistrich M L; Liang J C; McLaughlin P; Redman J R; Romaguera J E; Rodríguez M A; Swan F
NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Seminars in oncology 1990;17(6 Suppl 10):34-8; discussion 38-40.
1990: Cabanillas F; Rodríguez M A; Swan F
Recent trends in the management of lymphomas at M.D. Anderson Cancer Center.
Seminars in oncology 1990;17(6 Suppl 10):28-32; discussion 32-3.
1990: Romagurea J E; Velasquez W S; Silvermintz K B; Fuller L B; Hagemeister F B; McLaughlin P; Cabanillas F
Surgical debulking is associated with improved survival in stage I-II diffuse large cell lymphoma.
Cancer 1990;66(2):267-72.
1990: Sneige N; Dekmezian R H; Katz R L; Fanning T V; Lukeman J L; Ordoñez N F; Cabanillas F F
Morphologic and immunocytochemical evaluation of 220 fine needle aspirates of malignant lymphoma and lymphoid hyperplasia.
Acta cytologica 1990;34(3):311-22.
1990: Cabanillas F
Ifosfamide combinations in lymphoma.
Seminars in oncology 1990;17(2 Suppl 4):58-62.
1990: Ford R J; Goodacre A; Ramirez I; Mehta S R; Cabanillas F
Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor.
Blood 1990;75(6):1311-8.
1989: Taylor K M; Jagannath S; Spitzer G; Spinolo J A; Tucker S L; Fogel B; Cabanillas F F; Hagemeister F B; Souza L M
Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1791-9.
1989: Barlogie B; Velasquez W S; Alexanian R; Cabanillas F
Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1514-7.
1989: Swan F; Velasquez W S; Tucker S; Redman J R; Rodriguez M A; McLaughlin P; Hagemeister F B; Cabanillas F
A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1518-27.
1989: Cabanillas F; Pathak S; Grant G; Hagemeister F B; McLaughlin P; Swan F; Rodriguez M A; Trujillo J; Cork A; Butler J J
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma.
The American journal of medicine 1989;87(2):167-72.
1989: Velasquez W S; Jagannath S; Tucker S L; Fuller L M; North L B; Redman J R; Swan F; Hagemeister F B; McLaughlin P; Cabanillas F
Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data.
Blood 1989;74(2):551-7.
1989: Terjanian T; Blick M B; Shtalrid M; Manning J T; Trujillo J M; Cabanillas F
Philadelphia chromosome without breakpoint cluster region rearrangement in a case of Lennert's lymphoma of suppressor phenotype.
Hematological oncology 1989;7(3):189-94.
1989: Cabanillas F
Experience with ifosfamide combinations in malignant lymphomas.
Seminars in oncology 1989;16(1 Suppl 3):78-81.
1989: Katz R L; Gritsman A; Cabanillas F; Fanning C V; Dekmezian R; Ordonez N G; Barlogie B; Butler J J
Fine-needle aspiration cytology of peripheral T-cell lymphoma. A cytologic, immunologic, and cytometric study.
American journal of clinical pathology 1989;91(2):120-31.
1989: Cabanillas F F
Management of patients with low-grade follicular lymphoma.
American journal of clinical oncology 1989;12(1):81-7.
1989: Spinolo J A; Jagannath S; Dicke K A; Smith K E; Cabanillas F; Hagemeister F B; Horwitz L J; McLaughlin P; Swan F; Spitzer G
High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():233-8.
1988: Barlogie B; Alexanian R; Smallwood L; Cheson B; Dixon D; Dicke K; Cabanillas F
Prognostic factors with high-dose melphalan for refractory multiple myeloma.
Blood 1988;72(6):2015-9.
1988: McLaughlin P; Osborne B M; Johnston D; Jennings P; Butler J J; Cabanillas F; Barlogie B
Nucleic acid flow cytometry in large cell lymphoma.
Cancer research 1988;48(22):6614-9.
1988: McLaughlin P; Velasquez W S; Redman J R; Yung W K; Hagemeister F B; Rodriguez M A; Cabanillas F
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma.
Journal of the National Cancer Institute 1988;80(17):1408-12.
1988: Cabanillas F; Pathak S; Trujillo J; Manning J; Katz R; McLaughlin P; Velasquez W S; Hagemeister F B; Goodacre A; Cork A
Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma.
Cancer research 1988;48(19):5557-64.
1988: Cabanillas F
A review and interpretation of cytogenetic abnormalities identified in Hodgkin's disease.
Hematological oncology 1988;6(3):271-4.
1988: Cabanillas F; Pathak S; Trujillo J; Grant G; Cork A; Hagemeister F B; Velasquez W S; McLaughlin P; Redman J; Katz R
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.
Blood 1988;71(6):1615-7.
1988: Ince C; Blick M; Lee M; Pathak S; Vadhan-Raj S; Selvanayagam P; Gutterman J U; Cabanillas F
Bcl-1 gene rearrangements in B cell lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(6):343-6.
1988: Cabanillas F; Velasquez W S; McLaughlin P; Jagannath S; Hagemeister F B; Redman J R; Swan F; Rodriguez M A
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
Seminars in hematology 1988;25(2 Suppl 2):47-50.
1988: Anaissie E J; Fainstein V; Bodey G P; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie K B
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
The American journal of medicine 1988;84(3 Pt 2):581-9.
1988: Velasquez W S; Cabanillas F; Salvador P; McLaughlin P; Fridrik M; Tucker S; Jagannath S; Hagemeister F B; Redman J R; Swan F
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).
Blood 1988;71(1):117-22.
1987: Dixon D O; McLaughlin P; Hagemeister F B; Freireich E J; Fuller L M; Cabanillas F F; Gehan E A
Reporting outcomes in Hodgkin's disease and lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1670-2.
1987: Hagemeister F B; Tannir N; McLaughlin P; Salvador P; Riggs S; Velasquez W S; Cabanillas F
MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(4):556-61.
1987: Cabanillas F; Hagemeister F B; McLaughlin P; Velasquez W S; Riggs S; Fuller L; Smith T
Results of MIME salvage regimen for recurrent or refractory lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):407-12.
1987: Cabanillas F; Pathak S; Zander A; Goodacre A; Katz R; Sneige N; Trujillo J; Cork A; Manning J; Butler J J
Monosomy 21, partial duplication of chromosome 11, and structural abnormality of chromosome 1q21 in a case of lymphoma developing in a transplant recipient: characteristic abnormalities of secondary lymphoma?
Cancer genetics and cytogenetics 1987;24(1):7-10.
1986: Jagannath S; Dicke K A; Armitage J O; Cabanillas F F; Horwitz L J; Vellekoop L; Zander A R; Spitzer G
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease.
Annals of internal medicine 1986;104(2):163-8.
1985: Kalter S P; Riggs S A; Cabanillas F; Butler J J; Hagemeister F B; Mansell P W; Newell G R; Velasquez W S; Salvador P; Barlogie B
Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males.
Blood 1985;66(3):655-9.
1984: Kantarjian H M; McLaughlin P; Fuller L M; Dixon D O; Osborne B M; Cabanillas F F
Follicular large cell lymphoma: analysis and prognostic factors in 62 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(7):811-9.
1984: da Cunha M F; Meistrich M L; Fuller L M; Cundiff J H; Hagemeister F B; Velasquez W S; McLaughlin P; Riggs S A; Cabanillas F F; Salvador P G
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(6):571-7.
1983: Tannir N; Hagemeister F; Velasquez W; Cabanillas F
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(7):432-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Fernando Cabanillas

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Fernando Cabanillas (preview)

All Publications